# An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia

> **NCT00473434** · PHASE3 · COMPLETED · sponsor: **Janssen-Cilag Pty Ltd** · enrollment: 64 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Paliperidone

## Key facts

- **NCT ID:** NCT00473434
- **Lead sponsor:** Janssen-Cilag Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2012-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00473434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00473434, "An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00473434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*